BRAINCHIP HOLDINGS LIMITED (BRN)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
BRN - BRAINCHIP HOLDINGS LIMITED
FNArena Sector :
Medical Equipment & Devices
Year End: June
GICS Industry Group : Software & Services
Index: ASX300 | ALL-ORDS | ALL-TECH
FNArena Sector : Medical Equipment & Devices
Year End: June
Brainchip Holdings is a holding company for its subsidiaries which provide neural computing technology and artificial neural networks through digital hardware and software. It operates in Australia and the US and has been a listed company since 2011.
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$1.11
16 May |
OPEN $1.16 |
HIGH $1.20 |
23,011,571 LOW $1.11 |
-0.010| OTHER COMPANIES IN THE SAME SECTOR | |||
| ELX . PGC . AHZ . COH . FPH . IPD . LHC . NAN . RMD . SOM . HLA . MX1 . CAT . VHT . ONE . IDX . PME . CSX . 4DX . EMV . UBI . LDX . RAP . RVA . MEB . IME . PCK . CMP . CYC . IMR . VTI . OVN . EYE . CGS . CU6 . TRJ . EBR . AT1 . CBL . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
| Title | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | xxx | xxx | -1.6 |
| DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 2.1 M |
| Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 1.5 |
| Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -18.9 M |
| Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -1,320.84 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -114.03 % |
| Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -108.53 % |
| Return on Assets | xxx | xxx | xxx | xxx | xxx | -88.15 % |
| Return on Equity | xxx | xxx | xxx | xxx | xxx | -114.03 % |
| Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -90.58 % |
| Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -19.2 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
This is work in progress. Bear with us. It'll be amazing.
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
BRN STOCK CHART
FNArena News on BRN
| 1 |
Rudi’s View: A Bear Market Anomaly That ConfusesMay 05 2022 - Rudi's View |
| 2 |
January In Review: Interest Rates Weigh On Growth StocksFeb 07 2022 - Australia |
| 3 |
In Brief: Retail And Tech Stocks, Workforce, Biotechs & MilkDec 10 2021 - Weekly Reports |
| 4 |
November In Review: Third Consecutive Down Month For EquitiesDec 06 2021 - Australia |
| 5 |
The Chips Are Down: Risks And OpportunitiesOct 15 2021 - Australia |
Latest Medical Equipment & Devices News
| 1 |
Shortages Chip Away At ResMed’s Big BreakMar 30 2022 - Australia |
| 2 |
Opportunity for Fisher & Paykel HealthcareMar 25 2022 - Australia |
| 3 |
Distribution Anxiety For NanosonicsFeb 10 2022 - Australia |
| 4 |
Brokers Awake To ResMed’s PotentialJan 31 2022 - Australia |
| 5 |
Covid Benefits F&P Healthcare, For NowDec 06 2021 - Australia |
| 6 |
Will Shortages Limit Upside For ResMed?Nov 01 2021 - Australia |
| 7 |
Nanosonics Unveils Its New ProductAug 26 2021 - Australia |
| 8 |
Pro Medicus: Opportunity AwaitsAug 24 2021 - Technicals |
| 9 |
Breakout For CochlearAug 10 2021 - Technicals |
| 10 |
Will ResMed’s Market Share Gains Last?Aug 09 2021 - Australia |